Home・Aandelen Lijst・Novartis AG

Novartis AG

Gesloten

154.08 -0.05

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

153.5

Max

155.86

Belangrijke statistieken
By Trading Economics
Inkomsten	110M 3.3B
Verkoop	894M 14B
K/W Sectorgemiddelde	23.213 68.51
EPS	2.41
Dividendrendement	3.04
Winstmarge	22.654
Werknemers	75,267
EBITDA	526M 5.9B

Aanbevelingen
By TipRanks
Aanbevelingen	Neutraal
12 Maanden Prognose	+2.95% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	3.04% 2.29%

Marktinformatie
By TradingEconomics
Marktkapitalisatie	6.7B 292B
Vorige openingsprijs	154.13
Vorige sluitingsprijs	154.08

Novartis AG Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

5 aug 2026, 23:56 UTC

Cooper Companies Inc. shares are roughly flat in after-market trading. Market sentiment reflects concerns from a disappointing ADP employment report showing weak job growth.

5 aug 2026, 23:56 UTC

News

CACI International reported Q2 sales of $2.71 billion, exceeding expectations. Shares advanced in after-market trading following strong earnings and optimistic full-year guidance.

5 aug 2026, 23:56 UTC

CEVA Inc shares rose during after-market hours after earlier declines. Broader market sentiment was affected by a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Correlated Moves

Shares of KKR & Co Inc are lower in after-market trading, following volatility and a disappointing ADP employment report indicating weak job growth.

5 aug 2026, 23:56 UTC

L3Harris Technologies shares are higher in after-market hours, despite no specific news. Cautious sentiment follows a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Allison Transmission Holdings Inc shares are higher in after-market trading, reaching a high above the 20-day moving average amid a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Flex Ltd shares are higher in after-market hours, despite no specific news. Market sentiment reflects concerns from a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Correlated Moves

Ennis Inc shares declined in after-market trading, reflecting broader market sentiment following a disappointing ADP employment report indicating weak job growth.

5 aug 2026, 23:56 UTC

Correlated Moves

News

Social Media

Magnolia Oil & Gas reported net income of $181.8 million and adjusted EPS of $0.99, exceeding estimates, contributing to after-market gains.

5 aug 2026, 23:56 UTC

Correlated Moves

News

Entergy Corp shares rose in after-market trading, supported by a $35 million contract awarded to ICF for energy efficiency programs.

5 aug 2026, 23:56 UTC

Tyler Technologies shares advanced in after-hours trading, recovering from an earlier dip. The stock is positioned near the midpoint of its one-month trading range.

5 aug 2026, 23:56 UTC

Charles River Laboratories is higher in after-market hours, recovering from session lows. Broader market sentiment is affected by a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Corsair Gaming Inc shares are higher in after-market trading, reflecting strong performance despite a disappointing ADP employment report affecting market sentiment.

5 aug 2026, 23:56 UTC

Public Service Enterprise Group shares are higher in after-market trading amid broader market concerns from a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Sweetgreen Inc. shares are trading lower in after-market hours, reflecting broader market sentiment following a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Correlated Moves

Cheesecake Factory shares decline in after-market trading, retracing earlier gains amid broader market caution following a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Biomarin Pharmaceutical Inc shares are higher in after-market hours amid routine trading, with no specific news identified to explain the movement.

5 aug 2026, 23:56 UTC

Correlated Moves

News

Uranium Energy Corp gains in after-market trading, influenced by Cameco's rise amid cautious market sentiment following a weak ADP employment report.

5 aug 2026, 23:56 UTC

Correlated Moves

Ultra Clean Holdings shares rose in after-market hours, supported by a significant gain in Veeco Instruments. Broader market sentiment was affected by a weak ADP report.

5 aug 2026, 23:56 UTC

Snap Inc. shares are lower in after-market trading, with no specific news identified. Broader market sentiment is affected by a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

NIO Inc shares are higher in after-market trading, despite no specific news. Broader market sentiment is affected by a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Aaon Inc. shares are lower in after-market hours, influenced by a disappointing ADP employment report showing only 44,000 private sector jobs added in July.

5 aug 2026, 23:56 UTC

Correlated Moves

Social Media

Micron Technology Inc shares are lower in after-market hours, following a decline earlier. The stock's movement aligns with Western Digital's significant drop.

5 aug 2026, 23:56 UTC

Chipotle Mexican Grill shares were roughly flat in after-market trading. Broader market sentiment was influenced by a disappointing ADP employment report.

5 aug 2026, 23:56 UTC

Ionis Pharmaceuticals shares are lower in after-market hours, influenced by a disappointing ADP employment report revealing only 44,000 private sector jobs added in July.

5 aug 2026, 23:56 UTC

Twist Bioscience Corp shares rose in after-market trading, despite earlier declines. Market sentiment was affected by a disappointing ADP employment report.

5 aug 2026, 23:51 UTC

PulteGroup Inc. shares declined in after-market trading, reversing earlier gains amid cautious sentiment following disappointing U.S. employment data from the ADP report.

5 aug 2026, 23:51 UTC

Travelers Companies Inc. shares are lower in after-market trading, following weak private sector employment growth data from the ADP report.

5 aug 2026, 23:51 UTC

Correlated Moves

Kimco Realty Corp shares are higher in after-market trading, influenced by the broader real estate sector despite recent economic data indicating slower job growth.

5 aug 2026, 23:51 UTC

News

Global Net Lease raised its 2026 FFO guidance to $0.82-$0.85, aligning with estimates, contributing to after-market gains following its earnings report.

Peer Vergelijking

Prijswijziging

Novartis AG Prognose

Koersdoel

By TipRanks

2.95% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 159 USD 2.95%

Hoogste 180 USD

Laagste 139 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Novartis AG - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

Buy

Hold

Sell

Gebaseerd op 5 analisten die aandelenratings hebben gegeven aan Novartis AG - Dist in de afgelopen 3 maanden.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.